Low-Dose Imaging for Early Multi-disease Assessment & Prevention is a nonprofit initiative established to advance one of the most ambitious preventive medicine programs ever proposed: the LDCT Mega Trial. The initiative envisions using a single low-dose, non-contrast CT scan combined with artificial intelligence to detect multiple life-threatening diseases before symptoms develop, fundamentally transforming the way preventive healthcare is delivered. The proposed LDCT Mega Tr
Aug 71 min read
Ready to Unlock the Value in Your CT Scans?
Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.